SNCA and Parkinson disease: BDEVs from ND patients have been found to carry altered miRNA profiles, as shown in Table 1, with both AD and PD BDEVs carrying toxins such as Amyloid-β (Aβ) and α-synuclein (α-syn), respectively, which feature heavily in their pathology (Vandendriessche et al., 2020).